Gene therapy progress and prospects: nonviral vectors.

PubWeight™: 2.79‹?› | Rank: Top 1%

🔗 View Article (PMID 12457277)

Published in Gene Ther on December 01, 2002

Authors

T Niidome1, L Huang

Author Affiliations

1: Center for Pharmacogenetics, School of Pharmacy, 633 Salk Hall, University of Pittsburgh, Pittsburgh, PA 15213, USA.

Articles citing this

(truncated to the top 100)

Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl (2010) 4.14

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol (2009) 2.99

Ultrasonic drug delivery--a general review. Expert Opin Drug Deliv (2004) 1.94

Gene transfer of the Na+,K+-ATPase beta1 subunit using electroporation increases lung liquid clearance. Am J Respir Crit Care Med (2004) 1.79

Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics. Adv Drug Deliv Rev (2008) 1.74

Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J Control Release (2006) 1.64

State-of-the-art 2003 on PKU gene therapy. Mol Genet Metab (2004) 1.51

Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug Chem (2008) 1.43

Gene therapy for cancer: regulatory considerations for approval. Cancer Gene Ther (2015) 1.41

A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo. ACS Nano (2013) 1.22

Ultrasound-mediated DNA transfer for bacteria. Nucleic Acids Res (2007) 1.17

Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine (2006) 1.16

Substrate-mediated delivery from self-assembled monolayers: effect of surface ionization, hydrophilicity, and patterning. Acta Biomater (2005) 1.14

Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences. Genetica (2010) 1.13

Reducible poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection. Mol Ther (2009) 1.11

An electrically active microneedle array for electroporation. Biomed Microdevices (2010) 1.10

Physical methods of nucleic acid transfer: general concepts and applications. Br J Pharmacol (2009) 1.09

Nanoscale cell adhesion ligand presentation regulates nonviral gene delivery and expression. Nano Lett (2007) 1.09

Visualizing light-triggered release of molecules inside living cells. Nano Lett (2010) 1.07

PEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion. J Control Release (2007) 1.01

A small library of DNA-encapsulated supramolecular nanoparticles for targeted gene delivery. Chem Commun (Camb) (2010) 1.00

Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression. Gene Ther (2009) 0.99

Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries. J Control Release (2007) 0.98

Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res (2007) 0.94

Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery. J R Soc Interface (2009) 0.93

A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res Lett (2014) 0.93

Characterization of degradable polyelectrolyte multilayers fabricated using DNA and a fluorescently-labeled poly(β-amino ester): shedding light on the role of the cationic polymer in promoting surface-mediated gene delivery. Biomacromolecules (2012) 0.92

Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems. AAPS J (2006) 0.91

Transcriptional targeting of tumor endothelial cells for gene therapy. Adv Drug Deliv Rev (2009) 0.91

Intracellular trafficking of nucleic acids. Expert Opin Drug Deliv (2004) 0.90

Surface polyethylene glycol enhances substrate-mediated gene delivery by nonspecifically immobilized complexes. Acta Biomater (2007) 0.90

Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells. Int J Nanomedicine (2011) 0.89

IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritis. Mol Ther (2012) 0.89

Advanced targeted nanomedicine. J Biotechnol (2015) 0.87

Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals. Bioimpacts (2013) 0.87

Bioreducible polymers for therapeutic gene delivery. J Control Release (2014) 0.87

Strategies in gene therapy for glioblastoma. Cancers (Basel) (2013) 0.87

Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J Gastroenterol (2004) 0.86

Enabling customization of non-viral gene delivery systems for individual cell types by surface-induced mineralization. Biomaterials (2009) 0.86

Fabrication and characterization of DNA-loaded zein nanospheres. J Nanobiotechnology (2012) 0.85

Microbubble-enhanced ultrasound exposure improves gene transfer in vascular endothelial cells. World J Gastroenterol (2006) 0.85

Synthesis and characterization of degradable multivalent cationic lipids with disulfide-bond spacers for gene delivery. Biochim Biophys Acta (2011) 0.84

The convergence of quantum-dot-mediated fluorescence resonance energy transfer and microfluidics for monitoring DNA polyplex self-assembly in real time. Nanotechnology (2009) 0.84

Sonoporation-mediated gene transfer into adult rat dorsal root ganglion cells. J Biomed Sci (2010) 0.84

Gene therapy for lung neoplasms. Clin Chest Med (2011) 0.84

Glutamine-chitosan modified calcium phosphate nanoparticles for efficient siRNA delivery and osteogenic differentiation. J Mater Chem B Mater Biol Med (2015) 0.83

Gene-based therapies in Parkinson's disease. Neurotherapeutics (2014) 0.83

Optimization of brush-like cationic copolymers for nonviral gene delivery. Biomacromolecules (2012) 0.83

Incorporation of DOPE into Lipoplexes formed from a Ferrocenyl Lipid leads to Inverse Hexagonal Nanostructures that allow Redox-Based Control of Transfection in High Serum. Soft Matter (2012) 0.83

Microarray analysis of gene expression profiles in cells transfected with nonviral vectors. Mol Ther (2011) 0.83

Delivery of large biopharmaceuticals from cardiovascular stents: a review. Biomacromolecules (2007) 0.83

AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model. BMC Cancer (2012) 0.82

Efficient microbubble- and ultrasound-mediated plasmid DNA delivery into a specific rat liver lobe via a targeted injection and acoustic exposure using a novel ultrasound system. Mol Pharm (2012) 0.82

Encapsulation of plasmid DNA in calcium phosphate nanoparticles: stem cell uptake and gene transfer efficiency. Int J Nanomedicine (2011) 0.82

Gene- and viral-based therapies for brain tumors. Neurotherapeutics (2009) 0.81

Co-transcriptional production of RNA-DNA hybrids for simultaneous release of multiple split functionalities. Nucleic Acids Res (2013) 0.81

Cationic liposome coupled endostatin gene for treatment of peritoneal colon cancer. Clin Exp Metastasis (2010) 0.81

Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells. PLoS One (2011) 0.81

Pancreatic cancer gene therapy: from molecular targets to delivery systems. Cancers (Basel) (2011) 0.81

"Molecular trinity" for soft nanomaterials: Integrating nucleobases, amino acids, and glycosides to construct multifunctional hydrogelators. Soft Matter (2012) 0.81

Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer. J Nanobiotechnology (2013) 0.81

The role of surface chemistry-induced cell characteristics on nonviral gene delivery to mouse fibroblasts. J Biol Eng (2012) 0.80

Reprogramming of mice primary hepatocytes into insulin-producing cells by transfection with multicistronic vectors. J Diabetes Res (2014) 0.80

A promising gene delivery system developed from PEGylated MoS2 nanosheets for gene therapy. Nanoscale Res Lett (2014) 0.80

Liposome-nucleic acid immunotherapeutics. Expert Opin Drug Deliv (2008) 0.80

Direct head-to-head comparison of cationic liposome-mediated gene delivery to mesenchymal stem/stromal cells of different human sources: a comprehensive study. Hum Gene Ther Methods (2013) 0.80

Flow-through electroporation of mammalian cells in decoupled flow streams using microcapillaries. Biomicrofluidics (2014) 0.80

Cholesterol-peptide hybrids to form liposome-like vesicles for gene delivery. PLoS One (2013) 0.80

Stacking of Short DNA Induces the Gyroid Cubic-to-Inverted Hexagonal Phase Transition in Lipid-DNA Complexes. Soft Matter (2012) 0.79

Liver-directed gene therapy for dyslipidemia and diabetes. Curr Atheroscler Rep (2004) 0.79

Influence of charge ratio of liposome/DNA complexes on their size after extrusion and transfection efficiency. Int J Nanomedicine (2012) 0.79

A dendritic nano-sized hexanuclear ruthenium(II) complex as a one- and two-photon luminescent tracking non-viral gene vector. Sci Rep (2015) 0.79

Nucleofection: a new method for cutaneous gene transfer? J Biomed Biotechnol (2006) 0.79

Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid. Int J Mol Sci (2015) 0.79

Delivery of siRNA via cationic Sterosomes to enhance osteogenic differentiation of mesenchymal stem cells. J Control Release (2015) 0.79

Microneedles As a Delivery System for Gene Therapy. Front Pharmacol (2016) 0.78

Phenylketonuria: a review of current and future treatments. Transl Pediatr (2015) 0.78

Intra-articular delivery of anti-Hif-2α siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice. Gene Ther (2015) 0.78

Evaluation of biolistic gene transfer methods in vivo using non-invasive bioluminescent imaging techniques. BMC Biotechnol (2011) 0.78

Biophysical characterization of copolymer-protected gene vectors. Biomacromolecules (2010) 0.78

Antioxidant activity and antiapoptotic effect of Asparagus racemosus root extracts in human lung epithelial H460 cells. Exp Ther Med (2010) 0.78

Current status of non-viral gene therapy for CNS disorders. Expert Opin Drug Deliv (2016) 0.77

Theranostic agents for intracellular gene delivery with spatiotemporal imaging. Nano Today (2013) 0.77

Bioengineered silk gene delivery system for nuclear targeting. Macromol Biosci (2014) 0.77

Poly(ethylenimine) conjugated bioreducible dendrimer for efficient gene delivery. J Control Release (2015) 0.77

Biodistribution and blood clearance of plasmid DNA administered in arginine peptide complexes. Genet Vaccines Ther (2011) 0.77

Study of the UTMD-based delivery system to induce cervical cancer cell apoptosis and inhibit proliferation with shRNA targeting Survivin. Int J Mol Sci (2013) 0.77

Gene therapy: regulations, ethics and its practicalities in liver disease. World J Gastroenterol (2008) 0.77

Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models. Gene Ther (2014) 0.77

Gene therapy in head and neck cancer: a review. Postgrad Med J (2007) 0.77

Tumor suppressor gene-based nanotherapy: from test tube to the clinic. J Drug Deliv (2011) 0.77

Virus-Inspired Self-Assembly Nanofibers with Aggregation-Induced Emission for Highly Efficient and Visible Gene Delivery. ACS Appl Mater Interfaces (2017) 0.77

Efficient Nonviral Gene Therapy Using Folate-Targeted Chitosan-DNA Nanoparticles In Vitro. ISRN Pharm (2012) 0.76

Tertiary-amine functionalized polyplexes enhanced cellular uptake and prolonged gene expression. PLoS One (2014) 0.76

Development and characterization of an enhanced nonviral expression vector for electroporation cancer treatment. Mol Ther Methods Clin Dev (2014) 0.76

Gene therapy for inborn errors of liver metabolism: progress towards clinical applications. Ital J Pediatr (2008) 0.76

Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy. Mar Drugs (2014) 0.76

Multi-Functionality in Theranostic Nanoparticles: is more Always Better? J Nanomed Nanotechnol (2012) 0.76

Reducible, dibromomaleimide-linked polymers for gene delivery. Biomater Sci (2014) 0.76

Insight into the role of N,N-dimethylaminoethyl methacrylate (DMAEMA) conjugation onto poly(ethylenimine): cell viability and gene transfection studies. J Mater Sci Mater Med (2012) 0.76

Articles by these authors

(truncated to the top 100)

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett (1990) 5.14

Electron transfer by domain movement in cytochrome bc1. Nature (1998) 4.08

Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst (1997) 3.92

Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. Nat Genet (2001) 3.65

Ethical consideration of incidental findings on adult brain MRI in research. Neurology (2004) 3.56

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A (2000) 3.44

Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet (1998) 3.24

Alterations of the PPP2R1B gene in human lung and colon cancer. Science (1998) 3.14

Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood (2001) 3.00

A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun (1991) 2.72

Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol (2001) 2.69

Toxicity of ALS-linked SOD1 mutants. Science (2000) 2.69

Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis (2009) 2.68

Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther (2001) 2.67

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A (1993) 2.35

Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol (1998) 2.28

Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18

Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. J Virol (1996) 2.17

ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol (2001) 2.14

Enzymatic completion of mammalian lagging-strand DNA replication. Proc Natl Acad Sci U S A (1994) 2.11

The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta (1995) 2.10

Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08

Proteomic analysis of nucleoporin interacting proteins. J Biol Chem (2001) 2.06

Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol Carcinog (1998) 2.06

Polymorphisms in the taste receptor gene (Tas1r3) region are associated with saccharin preference in 30 mouse strains. J Neurosci (2004) 2.03

Transmembrane pH gradient and membrane potential in Clostridium acetobutylicum during growth under acetogenic and solventogenic conditions. Appl Environ Microbiol (1985) 2.02

Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta (1991) 2.01

Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol (1994) 2.00

Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene (2007) 1.95

Crystal structure of an activated response regulator bound to its target. Nat Struct Biol (2001) 1.95

Regulation of F-actin binding to platelet moesin in vitro by both phosphorylation of threonine 558 and polyphosphatidylinositides. Mol Biol Cell (1999) 1.91

New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett (1994) 1.90

Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol (2000) 1.86

Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther (1997) 1.86

Benchmark data and power calculations for evaluating disease outbreak detection methods. MMWR Morb Mortal Wkly Rep (2004) 1.86

Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther (2006) 1.84

Patterns of protein synthesis and tolerance of anoxia in root tips of maize seedlings acclimated to a low-oxygen environment, and identification of proteins by mass spectrometry. Plant Physiol (2000) 1.82

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest (2000) 1.82

Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann Neurol (2000) 1.82

The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther (1999) 1.81

Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta (1994) 1.79

A physical map of chromosome 2 of Arabidopsis thaliana. Genome Res (1996) 1.77

Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther (2001) 1.76

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol (2001) 1.73

A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol (2000) 1.71

Cationic liposome-mediated gene transfer. Gene Ther (1995) 1.68

Nonviral gene therapy: promises and challenges. Gene Ther (2000) 1.65

Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia. J Exp Med (2000) 1.65

Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol (1999) 1.61

Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res (2000) 1.60

Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry (1996) 1.60

Structure and function of lipid-DNA complexes for gene delivery. Annu Rev Biophys Biomol Struct (2000) 1.57

Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (2000) 1.56

Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem (1996) 1.55

Architectural design and tools to support the transparent access to hospital information systems, radiology information systems, and picture archiving and communication systems. J Digit Imaging (1996) 1.54

DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta (1994) 1.54

Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart (2006) 1.53

Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J Virol (2001) 1.51

An abundant DNA binding protein from the hyperthermophilic archaeon Sulfolobus shibatae affects DNA supercoiling in a temperature-dependent fashion. J Bacteriol (2000) 1.51

In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther (1997) 1.51

Resorcylic acid lactones: naturally occurring potent and selective inhibitors of MEK. J Antibiot (Tokyo) (1999) 1.51

Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta (1992) 1.50

The calf 5'- to 3'-exonuclease is also an endonuclease with both activities dependent on primers annealed upstream of the point of cleavage. J Biol Chem (1994) 1.49

Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation. Science (1979) 1.48

Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A (2007) 1.48

Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther (1999) 1.47

Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci (2001) 1.46

An Arabidopsis mutant with a reduced level of cab140 RNA is a result of cosuppression. Plant Cell (1993) 1.45

pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Sci U S A (1987) 1.44

Nomenclature for synthetic gene delivery systems. Hum Gene Ther (1997) 1.44

beta-Catenin is essential for patterning the maternally specified animal-vegetal axis in the sea urchin embryo. Proc Natl Acad Sci U S A (1998) 1.44

The structural basis for tRNA recognition and pseudouridine formation by pseudouridine synthase I. Nat Struct Biol (2000) 1.41

Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion. J Virol (1993) 1.40

Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell (2001) 1.40

pH-sensitive liposomes: acid-induced liposome fusion. Proc Natl Acad Sci U S A (1984) 1.40

Relationship between leptin and chronic inflammatory state in uremic patients. Eur Rev Med Pharmacol Sci (2014) 1.40

The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med (2000) 1.39

Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J Biol Chem (2001) 1.39

The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol (2001) 1.38

Production of a family of kinase-inhibiting lactones from fungal fermentations. J Antibiot (Tokyo) (1999) 1.37

Cryptic single-stranded-DNA binding activities of the phage lambda P and Escherichia coli DnaC replication initiation proteins facilitate the transfer of E. coli DnaB helicase onto DNA. Proc Natl Acad Sci U S A (1997) 1.37

Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology (2001) 1.36

Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther (1998) 1.36

Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci U S A (1993) 1.36

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J Exp Med (1992) 1.36

Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis? J Clin Microbiol (2010) 1.35

Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes (1996) 1.34

Geographic distribution of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in San Francisco. Am J Respir Crit Care Med (2000) 1.33

Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology (2000) 1.32

The nucleoporin Nup60p functions as a Gsp1p-GTP-sensitive tether for Nup2p at the nuclear pore complex. J Cell Biol (2001) 1.32

Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology (2000) 1.31

Purification and characterization of shikimate kinase enzyme activity in Bacillus subtilis. J Biol Chem (1975) 1.30

Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther (1992) 1.28

Disruption of dynamic cell surface architecture of NIH3T3 fibroblasts by the N-terminal domains of moesin and ezrin: in vivo imaging with GFP fusion proteins. J Cell Sci (1999) 1.28

Adsorption/aggregation of surfactants and their mixtures at solid-liquid interfaces. Adv Colloid Interface Sci (2000) 1.27

Interaction of phospholipid vesicles with cultured mammalian cells. II. Studies of mechanism. J Cell Biol (1975) 1.26

Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol (2001) 1.25

Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. Br J Cancer (2010) 1.25

Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry (1998) 1.24

Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int (2004) 1.24